OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 146 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $30,000 | -62.0% | 53,910 | +17.4% | 0.00% | -100.0% |
Q4 2015 | $79,000 | -18.6% | 45,927 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $97,000 | -57.3% | 45,927 | 0.0% | 0.00% | -50.0% |
Q2 2015 | $227,000 | -36.9% | 45,927 | 0.0% | 0.00% | -33.3% |
Q1 2015 | $360,000 | +29.5% | 45,927 | 0.0% | 0.00% | +50.0% |
Q4 2014 | $278,000 | +41.8% | 45,927 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $196,000 | -31.0% | 45,927 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $284,000 | -5.0% | 45,927 | 0.0% | 0.00% | -33.3% |
Q1 2014 | $299,000 | +15.4% | 45,927 | 0.0% | 0.00% | +50.0% |
Q4 2013 | $259,000 | -8.2% | 45,927 | 0.0% | 0.00% | -33.3% |
Q3 2013 | $282,000 | +4.8% | 45,927 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $269,000 | – | 45,927 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 3,000,000 | $5,160,000 | 4.58% |
Foresite Capital Management II, LLC | 6,225,049 | $10,707,000 | 3.59% |
Scale Management, LLC | 1,312,575 | $2,258,000 | 3.46% |
NEA Management Company, LLC | 3,709,000 | $6,379,000 | 0.41% |
Cheyne Capital Management (UK) LLP | 413,200 | $709,000 | 0.38% |
Rhenman & Partners Asset Management AB | 1,189,000 | $2,045,000 | 0.31% |
SAMLYN CAPITAL, LLC | 6,160,417 | $10,596,000 | 0.22% |
Rock Springs Capital Management LP | 1,650,000 | $2,838,000 | 0.22% |
Palo Alto Investors LP | 1,673,024 | $2,878,000 | 0.16% |
GLOBEFLEX CAPITAL L P | 295,000 | $507,000 | 0.14% |